Illumina Acquires GRAIL For $8 Billion
socalTECH
SEPTEMBER 21, 2020
San Diego-based life sciences equipment maker Illumina announced this morning that it has acquired Menlo Park-based GRAIL , a developer of cancer early detection technology. GRAIL is developing a multi-cancer screening test. According to Illumina, it will acquire GRAIL for cash and stock worth $8 billion. billion in cash and $4.5
Let's personalize your content